Date: 6. April 2020
Time: 16-17:30h CEST
To join the webinar please click here:
https://zoom.us/j/284555212
The current situation related to the Covid-19 pandemic causes a lot of strain
and isolation in HD patients and their families. All the restrictions imply big
changes in daily life and the routines are hard to maintain. In order to
support the persons concerned in this situation we will have a panel of 14 HD
experts in different medical specialities able to respond in more than 15
different languages.
The webinar will give you information about the specific risks for HD patients,
update on consequences for the ongoing HD studies and trials, and some advice
on how to cope with the new situation.
Confirmed speakers:
Astri Arnesen – European Huntigton Association
Professor Bernhard Landwehrmeyer (Neurologist) – Germany
Alzbeta Muehlbaeck (Neuropsychiatrist ) – Germany/Slovakia
Professor Anne-Catherine Bahoud Levi (Neurologist) – France
Professor Hugh Rickards (Psychiatrist) – UK
Dr Yuri Seliverstov (Neurologist) – Russia
Natalia Grigorova (Psychologist) – Bulgaria
Filipa Julio (Neuropsychologist) –
Portugal
Dr Alzbeta Muehlbaeck (Neuropsychiatrist) – Germany
Professor Maria Judit Molnar (Neurogeneticist) – Hungary
Dr Jose Lopez Sendon (Neurologist) – Spain
Dr Lasse Philstrøm (Neurologist) – Norway
Ramona Moldova (Neuropsychologist ) – Romania
Dr Wioletta Krysa (Geneticist ) – Poland
Professor Ferdinando Squitieri (Neurologist) – Italy
The primary target audience are patients and patients’ family members but
clinicians are also very welcome to attend.
All the information about this webinar can be found here: https://bit.ly/2WZ3asZ
